KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other financing activities (2016 - 2025)

Merck (MRK) has disclosed Other financing activities for 17 consecutive years, with $121.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 388.1% to $121.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$131.0 million, a 64.78% increase, with the full-year FY2025 number at -$131.0 million, up 64.78% from a year prior.
  • Other financing activities was $121.0 million for Q4 2025 at Merck, up from $2.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $121.0 million in Q4 2025 to a low of -$407.0 million in Q2 2021.
  • A 5-year average of -$87.5 million and a median of -$73.0 million in 2022 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: plummeted 1300.0% in 2024, then soared 388.1% in 2025.
  • Merck's Other financing activities stood at -$407.0 million in 2021, then soared by 83.29% to -$68.0 million in 2022, then soared by 95.59% to -$3.0 million in 2023, then tumbled by 1300.0% to -$42.0 million in 2024, then surged by 388.1% to $121.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Other financing activities are $121.0 million (Q4 2025), $2.0 million (Q3 2025), and -$194.0 million (Q2 2025).